Deep-Dive Due Diligence AI Generated Report on Know Labs, Inc. (KNW)

Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.

These reports are generated using OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.

Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.


KNW_OUT_1 [2025-04-01 05:16:56 -0400] 2055 Bytes | 600 tokens | Cum: 600 tkns (7.50% of 8k)
==========================================================================

We're scouting for winners today. Its 5:16:55 AM on Tue Apr 01, 2025 -0400 and I'm looking at Know Labs (KNW) up to 0.797 from 0.68

Help me investigate to see if its got potential or just another dud. So, I pulled together a bunch of data for you to look over real fast.

Here's the first list of news for Know Labs:

C1 - Mar-19-25 09:00AM - Know Labs Sensor Non-Invasively Identifies pH Levels in Real Time
C2 - Mar-18-25 09:00AM - Know Labs to Attend the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
C3 - Jan-30-25 09:00AM - Know Labs Responds to NYSE Commencement of Proceedings to Delist
C4 - Jan-21-25 05:00AM - Know Labs Launches Know Labs Technology Licensing (KTL)
C5 - Dec-13-24 09:00AM - Know Labs, Inc. Announces $300K Registered Direct Offering
C6 - Dec-11-24 09:00AM - Know Labs, Inc. Announces NYSE American Acceptance of Plan to Regain Compliance

Prior AI Reports for KNW:
1. 2025-03-31 – Score: 8 – Target: 0.8800 – Highs: 0.8000 / – / –
financial-turmoil-ahead-companys-dire-performance-indicates-potential-downfall
2. 2025-03-25 – Score: 10 – Target: 1.2900 – Highs: 1.0500 / 0.9600 / 0.89
know-labs-faces-steep-challenges-amid-negative-growth-and-high-risk

(Note: Highs = Same day / 2nd day / 3rd day)

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Know Labs (KNW)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

KNW_IN_2 [2025-04-01 05:16:56 -0400] 2 Bytes | 2 tokens | Cum: 602 tkns (7.52% of 8k)
==========================================================================

C1

KNW_OUT_3 [2025-04-01 05:17:01 -0400] 1100 Bytes | 279 tokens | Cum: 881 tkns (11.01% of 8k)
==========================================================================

Showing C1 (chunk 1 of 9): C1:
**Know Labs Sensor Non-Invasively Identifies pH Levels in Real Time**
Date: Mar-19-25 09:00AM
Source: (Business Wire)
URL: https://finance.yahoo.com/news/know-labs-sensor-non-invasively-130000068.html

Significant Applications in Health Care, Food Quality and Safety and More

SEATTLE, March 19, 2025--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) is pleased to announce that it has completed extensive research in its laboratory utilizing its patented Radio Frequency Dielectric Spectroscopy (RFDS) sensor technology to identify changes in pH levels in real time. The research has been submitted for peer reviewed publication. Theresearchis available for review todayhereon the Company’s website atwww.knowlabs.co.

An abstract of the paper states, "We describe an experiment in which we employ a radio frequency sensor to measure pH changes in a liquid solution. The experiment is novel

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

KNW_IN_4 [2025-04-01 05:17:01 -0400] 467 Bytes | 84 tokens | Cum: 965 tkns (12.06% of 8k)
==========================================================================

Know Labs, Inc. has announced the completion of extensive research into its patented Radio Frequency Dielectric Spectroscopy (RFDS) sensor technology's ability to identify changes in pH levels in real time. The research, which is currently available for review, outlines a novel experiment using a radio frequency sensor to measure pH changes in a liquid solution. This technology has significant applications in various fields, including health care and food safety.

KNW_OUT_5 [2025-04-01 05:17:01 -0400] 957 Bytes | 302 tokens | Cum: 1267 tkns (15.84% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-31T12:05:38Z - 12 Health Care Stocks Moving In Monday's Pre-Market Session - Aprea Therapeutics (NASDAQ:APRE), Apol...
A2 - 2025-03-31T08:58:25Z - Why Xos Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Color Star Tec...
A3 - 2025-03-28T21:05:46Z - 12 Health Care Stocks Moving In Friday's After-Market Session - bluebird bio (NASDAQ:BLUE), Biodesix...
A4 - 2025-03-27T07:04:54Z - Know Labs (NYSEAMERICAN:KNW) Shares Down 7.5% - Here's What Happened...
A5 - 2025-03-25T12:48:00Z - Pre-market Movers: TNON, POAI, MURA, KNW, IMTE....

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

KNW_IN_6 [2025-04-01 05:17:01 -0400] 2 Bytes | 2 tokens | Cum: 1269 tkns (15.86% of 8k)
==========================================================================

A1

KNW_OUT_7 [2025-04-01 05:17:09 -0400] 1098 Bytes | 336 tokens | Cum: 1605 tkns (20.06% of 8k)
==========================================================================

Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Monday's Pre-Market Session - Aprea Therapeutics (NASDAQ:APRE), Apollomics (NASDAQ:APLM)**Date: 2025-03-31Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/03/44559530/12-health-care-stocks-moving-in-mondays-pre-market-sessionGainers Citius Oncology CTOR stock moved upwards by 66.9% to $1.11 during Monday's pre-market session. The market value of their outstanding shares is at $79.4 million. Corcept Therapeutics CORT shares rose 44.99% to $79.21. The market value of their outstanding shares is at $8.3 billion. Spruce Biosciences SPRB shares moved upwards by 18.6% to $0.35. The market value of their outstanding shares is at $14.4 million. Apollomics APLM shares rose 17.73% to $8.96. The market value of their outstanding shares is at $9.8 million. Know Labs KNW shares moved upwards

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

KNW_IN_8 [2025-04-01 05:17:09 -0400] 685 Bytes | 186 tokens | Cum: 1791 tkns (22.39% of 8k)
==========================================================================

This report highlights the pre-market movements of 12 health care stocks on Monday. Citius Oncology (CTOR) saw its stock increase by 66.9% to $1.11, bringing the market value of its outstanding shares to $79.4 million. Corcept Therapeutics (CORT) experienced a rise of 44.99% to $79.21, making the market value of its outstanding shares $8.3 billion. Spruce Biosciences (SPRB) saw a rise of 18.6% to $0.35, with the market value of its outstanding shares standing at $14.4 million. Apollomics (APLM) experienced an increase of 17.73% to $8.96, bringing the market value of its outstanding shares to $9.8 million. Lastly, Know Labs (KNW) also saw an upward movement in its stock prices.

KNW_OUT_9 [2025-04-01 05:17:09 -0400] 1024 Bytes | 308 tokens | Cum: 2099 tkns (26.24% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-12-17T15:00:00Z - Verselabs introduces verseOS: The Web3-Native Operating System Empowering Seamless Web3 Experience
B2 - 2024-03-01T13:31:07Z - Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
B3 - 2023-12-26T19:43:36Z - Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher
B4 - 2023-12-26T18:48:21Z - Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B5 - 2023-12-20T18:16:08Z - Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
B6 - 2023-12-18T18:05:04Z - Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

KNW_IN_10 [2025-04-01 05:17:09 -0400] 2 Bytes | 2 tokens | Cum: 2101 tkns (26.26% of 8k)
==========================================================================

B1

KNW_OUT_11 [2025-04-01 05:17:13 -0400] 833 Bytes | 219 tokens | Cum: 2320 tkns (29.00% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Verselabs introduces verseOS: The Web3-Native Operating System Empowering Seamless Web3 Experience**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2024/12/17/2998415/0/en/Verselabs-introduces-verseOS-The-Web3-Native-Operating-System-Empowering-Seamless-Web3-Experience.htmlVerselabs has unveiled verseOS, a Web3-native operating system designed to simplify and enhance the Web3 experience. The OS aims to address the complexity and fragmentation that has hindered mass adoption of Web3 technologies, offering a unified ecosystem, seamless onboarding, and developer-friendly integration.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

KNW_IN_12 [2025-04-01 05:17:13 -0400] 522 Bytes | 95 tokens | Cum: 2415 tkns (30.19% of 8k)
==========================================================================

Verselabs has launched verseOS, a Web3-native operating system designed to streamline and improve the Web3 experience. The new OS aims to tackle the complexity and fragmentation that has been a barrier to widespread adoption of Web3 technologies. It offers a unified ecosystem, smooth onboarding, and easy integration for developers. The financial implications of this could be significant if verseOS successfully simplifies the use of Web3 technologies, potentially leading to increased adoption and growth in the sector.

KNW_OUT_13 [2025-04-01 05:17:14 -0400] 1142 Bytes | 308 tokens | Cum: 2723 tkns (34.04% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-02-28 8-K Item 7.01 Regulation FD Disclosure.

On February 28, 2025, the Company issued a press release regarding lifting of the trading suspension of the Companys common stock on the NYSE American effective March 5, 2025 and as described in this Curr Report on Form 8-K (Report). A cop...

S2 - 2025-02-28 8-K Item 7.01 Regulation FD Disclosure.

On February 28, 2025, the Company issued a press release regarding lifting of the trading suspension of the Companys common stock on the NYSE American effective March 5, 2025 and as described in this Curr Report on Form 8-K (Report). A cop...

S3 - 2025-02-28 8-K Item 7.01 Regulation FD Disclosure.

On February 28, 2025, the Company issued a press release regarding lifting of the trading suspension of the Companys common stock on the NYSE American effective March 5, 2025 and as described in this Curr Report on Form 8-K (Report). A cop...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

KNW_IN_14 [2025-04-01 05:17:14 -0400] 2 Bytes | 2 tokens | Cum: 2725 tkns (34.06% of 8k)
==========================================================================

S1

KNW_OUT_15 [2025-04-01 05:17:20 -0400] 959 Bytes | 246 tokens | Cum: 2971 tkns (37.14% of 8k)
==========================================================================

Showing S1 (chunk 1 of 1): S1:
Item 7.01 Regulation FD Disclosure.

On February 28, 2025, the Company issued a press release regarding lifting of the trading suspension of the Companys common stock on the NYSE American effective March 5, 2025 and as described in this Current Report on Form 8-K (Report). A copy of the press release is attached as Exhibit 99.1 to this Report. The information included in this Item 7.01 of this Report, including the attached Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing....

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

KNW_IN_16 [2025-04-01 05:17:20 -0400] 538 Bytes | 120 tokens | Cum: 3091 tkns (38.64% of 8k)
==========================================================================

The company issued a press release on February 28, 2025, announcing the lifting of the trading suspension of its common stock on the NYSE American, which will be effective from March 5, 2025. This information was provided in the Current Report on Form 8-K and an attached press release (Exhibit 99.1). However, this information is not deemed filed for the purposes of Section 18 of the Securities Exchange Act of 1934, or incorporated by reference in any filing under the Securities Act of 1933, unless explicitly stated in such a filing.

KNW_OUT_17 [2025-04-01 05:17:28 -0400] 4156 Bytes | 1185 tokens | Cum: 4276 tkns (53.45% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+---------------------+-----------------------+------------------------+----------------------+
| Volume: 170,035 | Perf Month: -80.83% | Option/Short: No / Yes | Sales Y/Y TTM: - |
+---------------------+-----------------------+------------------------+----------------------+
| Avg Volume: 117.70K | Perf Quarter: -89.85% | Short Float: 3.38% | ROE: -2088.74% |
+---------------------+-----------------------+------------------------+----------------------+
| Rel Volume: 1.44 | Index: - | Short Ratio: 0.60 | ROI: - |
+---------------------+-----------------------+------------------------+----------------------+
| RSI (14): 29.20 | Market Cap: 1.91M | Short Interest: 0.07M | Sales Surprise: - |
+---------------------+-----------------------+------------------------+----------------------+
| ATR (14): 0.60 | Shs Outstand: 2.78M | Beta: 1.51 | EPS Surprise: - |
+---------------------+-----------------------+------------------------+----------------------+
| SMA20: -57.90% | Shs Float: 2.09M | Sales Q/Q: - | P/E: - |
+---------------------+-----------------------+------------------------+----------------------+
| SMA50: -76.38% | Inst Own: 3.22% | Sales past 5Y: -58.65% | Earnings: Feb 14 AMC |
+---------------------+-----------------------+------------------------+----------------------+
| SMA200: -92.83% | Insider Own: 25.48% | Employees: 12 | |
+---------------------+-----------------------+------------------------+----------------------+
| Perf Week: -35.24% | Insider Trans: 0.00% | Debt/Eq: - | |
+---------------------+-----------------------+------------------------+----------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -16581558.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.68
Average Volume: 235905.84
30-Day High: 3.06
30-Day Low: 0.68

[Detailed Financials: TTM 2024]
- Total Assets: $3,664,428.0
- Total Liabilities: $5,820,629.0
- Total Equity: $-2,156,201.0
- Current Assets: $3,110,755.0
- Current Liabilities: $5,163,379.0

[Income Statement: TTM 2024]
- Revenue: $0.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): N/A

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $-4,912,961.0

[Detailed Financials: FY 2024]
- Total Assets: $3,664,428.0
- Total Liabilities: $5,820,629.0
- Total Equity: $-2,156,201.0
- Current Assets: $3,110,755.0
- Current Liabilities: $5,163,379.0

[Income Statement: FY 2024]
- Revenue: $0.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): N/A

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $-4,912,961.0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

KNW_IN_18 [2025-04-01 05:17:28 -0400] 1037 Bytes | 218 tokens | Cum: 4494 tkns (56.17% of 8k)
==========================================================================

1) Brief Summary: The company appears to be in a dire financial state with negative total equity, no reported revenue, and a significant net cash flow loss. Performance metrics show a severe decline over the past month, quarter, and year, with a nearly 90% drop in the past quarter alone. The company has very high insider ownership, but institutional ownership is low. The average volume is higher than usual, which may indicate more investor interest or potentially more selling pressure. The stock's beta is above 1, indicating it's more volatile than the market.

2) MARKET_SCORE: Given the negative financial health and poor performance metrics, the likelihood of an upward move is low. MARKET_SCORE[20]

3) PRICE_TARGET: Considering the company's negative financials and declining performance, it's difficult to predict a higher price target. However, if the company can turn around its operations, it may see some recovery. PRICE_TARGET[$0.85]

4) AI_RPT_HEADLINE: "Company's Financial Health in Jeopardy as Performance Plummets"

KNW_OUT_19 [2025-04-01 05:17:32 -0400] 676 Bytes | 167 tokens | Cum: 4661 tkns (58.26% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

KNW_IN_20 [2025-04-01 05:17:32 -0400] 344 Bytes | 71 tokens | Cum: 4732 tkns (59.15% of 8k)
==========================================================================

As a financial analyst, my choice would be X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes. This is because these documents contain comprehensive information about a company's financial health, business operations, and potential risks, which can help in making a more accurate and confident analysis.

KNW_IN_21 [2025-04-01 05:17:33 -0400] 126 Bytes | 29 tokens | Cum: 4761 tkns (59.51% of 8k)
==========================================================================

====================================
[2025-04-01 05:17:33] # Analysis Completed
Elapsed Time: 37.61 seconds




Scroll to Top